Status:
UNKNOWN
Indocyanine Green Fluorescence Imaging, Sentinel Lymph Node Mapping in Patients With Vulvar Cancer
Lead Sponsor:
Azienda Ospedaliera per l'Emergenza Canizzaro
Conditions:
Vulvar Cancer
Eligibility:
FEMALE
20-100 years
Phase:
NA
Brief Summary
The potential of the administration of indocyanine green (ICG) allows the execution of SLN biopsy, avoiding the multiple administrations of radiocolloid in the pre-operative phase, painful for the pat...
Detailed Description
According to The European Society of Gynaecological Oncology (ESGO) guidelines, the investigators decided to treat patients with vulvar squamous cell carcinoma (vSCC), FIGO stage IB with radical vulve...
Eligibility Criteria
Inclusion
- patients diagnosed with vulvar squamous cell carcinoma FIGO IB stage
Exclusion
- \-
Key Trial Info
Start Date :
July 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 20 2023
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT04663412
Start Date
July 9 2020
End Date
July 20 2023
Last Update
December 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ginecologia e Ostetricia
Catania, Italy, 95126